Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Hikma Pharmaceuticals

    PNK: HKMPF · Real-Time Price · USD
    26.93
    0.73 (2.80%)
    At close: May 07, 2025, 12:33 PM

    Hikma Pharmaceuticals Statistics

    Share Statistics

    Hikma Pharmaceuticals has 220.43M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 220.43M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 152.55M

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is 14.87 and the forward PE ratio is null. Hikma Pharmaceuticals's PEG ratio is 0.17.

    PE Ratio

    n/a
    		 14.87

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 1.71

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 2.31

    P/FCF Ratio

    n/a
    		 13.38

    PEG Ratio

    n/a
    		 0.17
    Financial Ratio History

    Enterprise Valuation

    Hikma Pharmaceuticals has an Enterprise Value (EV) of 6.46B.

    EV / Sales

    n/a
    		 2.06

    EV / EBITDA

    n/a
    		 8.2

    EV / EBIT

    n/a
    		 11.45

    EV / FCF

    n/a
    		 16.18

    Financial Position

    The company has a current ratio of 1.14, with a Debt / Equity ratio of 0.57.

    Current Ratio

    n/a
    		 1.14

    Quick Ratio

    n/a
    		 0.65

    Debt / Equity

    n/a
    		 0.57

    Debt / EBITDA

    n/a
    		 1.66

    Debt / FCF

    n/a
    		 3.27

    Interest Coverage

    n/a
    		 8.16

    Financial Efficiency

    Return on Equity is 15.54% and Return on Invested Capital is 12.79%.

    Return on Equity

    n/a
    		 15.54%

    Return on Assets

    n/a
    		 6.99%

    Return on Invested Capital

    n/a
    		 12.79%

    Revenue Per Employee

    n/a
    		 $329,157.89

    Profits Per Employee

    n/a
    		 $37,789.47

    Employee Count

    n/a
    		 9,500

    Asset Turnover

    n/a
    		 0.61

    Inventory Turnover

    n/a
    		 1.74

    Taxes

    Income Tax

    n/a
    		 93M

    Effective Tax Rate

    n/a
    		 20.44%

    Stock Price Statistics

    The stock price has increased by 6.94% in the last 52 weeks. The beta is 0.63, so Hikma Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.63

    52-Week Price Change

    n/a
    		 6.94%

    50-Day Moving Average

    n/a
    		 26.54

    200-Day Moving Average

    n/a
    		 25.5

    Relative Strength Index (RSI)

    n/a
    		 37.05

    Average Volume (20 Days)

    n/a
    		 245

    Income Statement

    In the last 12 months, Hikma Pharmaceuticals had revenue of 3.13B and earned 359M in profits. Earnings per share was 1.61.

    Revenue

    n/a
    		 3.13B

    Gross Profit

    n/a
    		 1.42B

    Operating Income

    n/a
    		 612M

    Net Income

    n/a
    		 359M

    EBITDA

    n/a
    		 787M

    EBIT

    n/a
    		 608M

    Earnings Per Share (EPS)

    n/a
    		 1.61
    Full Income Statement

    Balance Sheet

    The company has 188M in cash and 1.31B in debt, giving a net cash position of -1.12B.

    Cash & Cash Equivalents

    n/a
    		 188M

    Total Debt

    n/a
    		 1.31B

    Net Cash

    n/a
    		 -1.12B

    Retained Earnings

    n/a
    		 2.36B

    Total Assets

    n/a
    		 5.13B

    Working Capital

    n/a
    		 285M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 564M and capital expenditures -165M, giving a free cash flow of 399M.

    Operating Cash Flow

    n/a
    		 564M

    Capital Expenditures

    n/a
    		 -165M

    Free Cash Flow

    n/a
    		 399M

    FCF Per Share

    n/a
    		 1.8
    Full Cash Flow Statement

    Margins

    Gross margin is 45.25%, with operating and profit margins of 19.57% and 11.48%.

    Gross Margin

    n/a
    		 45.25%

    Operating Margin

    n/a
    		 19.57%

    Pretax Margin

    n/a
    		 14.55%

    Profit Margin

    n/a
    		 11.48%

    EBITDA Margin

    n/a
    		 25.17%

    EBIT Margin

    n/a
    		 19.57%

    FCF Margin

    n/a
    		 12.76%

    Dividends & Yields

    HKMPF pays an annual dividend of $1.27, which amounts to a dividend yield of 3.05%.

    Dividend Per Share

    n/a
    		 $1.27

    Dividend Yield

    n/a
    		 3.05%

    Dividend Growth (YoY)

    n/a
    		 2.18%

    Payout Ratio

    n/a
    		 78.84%

    Earnings Yield

    n/a
    		 6.72%

    FCF Yield

    n/a
    		 7.47%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for HKMPF.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 3.9

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist